A subunit vaccine for multiple respiratory viruses
Science Advances · 2026
DOI: 10.1126/sciadv.aea3227 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Qinzhe Li und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, State University of New York at Buffalo, Buffalo, NY 14260, USA. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institutes of Health, McGill University.
Abstract (Originalsprache)
Seasonal influenza viruses, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and respiratory syncytial virus (RSV) drive substantial mortality worldwide. Vaccines against these respiratory viruses are traditionally administered separately, and, while some emerging technologies have shown promise to address multiple pathogens simultaneously, subunit protein vaccines have lagged behind. Here, we describe a nanoliposome-based vaccine platform that codisplays recombinant hemagglutinin ectodomains from three seasonal influenza strains, the SARS-CoV-2 receptor binding domain, and the RSV F ectodomain, in prefusion form. In mouse, ferret, and cotton rat models, immunization elicited protective immunity against the three major respiratory viruses, with antibody responses comparable to those induced by the corresponding monovalent formulations. These findings highlight the potential for multivalent recombinant protein vaccines delivered via nanoliposome carriers to provide immunologic protection against a broad spectrum of respiratory viruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, State University of New York at Buffalo, Buffalo, NY 14260, USA.
- POP Biotechnologies, Buffalo, NY 14228 USA.
- Host-pathogen interactions (HPI) and Disease Intervention and Prevention (DIP) programs, Texas Biomedical Research Institute, San Antonio, TX 78227 USA.
- Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.
- Department of Anatomy and Cell Biology, McGill University, Montreal, QC H3A 0C7, Canada.
- Department of Anesthesiology, State University of New York at Buffalo, Buffalo, NY 14203, USA.
ORCID-Profile: Qinzhe Li, Wei-Chiao Huang, Sara H Mahmoud, Chengjin Ye, Zachary R Sia, Hilliard L Kutscher, Wen-Ling Hsu, Dominic Arpin, Joaquin Ortega, Luis Martinez-Sobrido, Bruce A Davidson, Jonathan F Lovell
Förderung
- National Institutes of Health
- McGill University
Zitieren
APA
Li, Q., Huang, W. C., Mahmoud, S. H., Ye, C., Sia, Z. R., Song, Y., Jiao, Y., Luo, Y., Zhou, S., Pul, R. M., Kutscher, H. L., Hsu, W. L., Arpin, D., Ortega, J., Martinez-Sobrido, L., Davidson, B. A., & Lovell, J. F. (2026). A subunit vaccine for multiple respiratory viruses. Science Advances. https://doi.org/10.1126/sciadv.aea3227
Vancouver
Li Q, Huang WC, Mahmoud SH, Ye C, Sia ZR, Song Y, et al. A subunit vaccine for multiple respiratory viruses. Science Advances. 2026. doi:10.1126/sciadv.aea3227
BibTeX
@article{Li2026,
author = {Li, Qinzhe and Huang, Wei-Chiao and Mahmoud, Sara H and Ye, Chengjin and Sia, Zachary R and Song, Yiting and Jiao, Yang and Luo, Yuan and Zhou, Shiqi and Pul, Reuben M and Kutscher, Hilliard L and Hsu, Wen-Ling and Arpin, Dominic and Ortega, Joaquin and Martinez-Sobrido, Luis and Davidson, Bruce A and Lovell, Jonathan F},
title = {A subunit vaccine for multiple respiratory viruses},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.aea3227}
}
EUVIMED